The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma

• Status: Unknown status
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to evaluate the feasibility of indocyanine green (ICG)-based fluorescence imaging in the detection of liver tumors. By correlating the ICG fluorescence patterns with pathologically confirmed tumors , it would be possible to use fluorescence navigation system in helping promoting oncology treatment.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhujiang Hospital

Criteria

Inclusion Criteria:

• 18 years≤ Age ≤70 years

• Compling with the diagnosis criteria of hepatic carcinoma.

• Primary hepatic carcinoma without intrahepatic or extrahepatic extensive cancer metastasis, the metastatic hepatic carcinoma whose primary focal has been controlled.

• Preoperative liver function is Child - Pugh grade A or B.

• The patients are volunteered for the study.

Exclusion Criteria:

• Patients with mental illness.

• Patients can't tolerate the operation owe to a variety of basic diseases (such as severe cardiopulmonary insufficiency, renal insufficiency, cachexia and blood system diseases, etc.

• The patients refused to take part in the study.

• There are other co-existed malignant tumors.

• Benign liver diseases.

• Indocyanine green allergy